nach oben

Clinical Neuroradiology

Erschienen in:

07.02.2019 | Clinical Case

Freiburg Neuropathology Case Conference

Posterior Fossa Mass in an Infant

Erschienen in: Clinical Neuroradiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 10-month-old boy became conspicuous 4–6 weeks before hospital admission with backward tilting of his head. He was finally admitted to hospital for decreased vigilance that had started 2 days prior to admission. Apart from anisocoric pupils the patient did not show any neurological deficits on admission. Magnetic resonance imaging (MRI) of the head showed an obstructive hydrocephalus in relation with a massive posterior fossa tumor. An external ventricular drainage was immediately placed. The subsequent craniotomy and operative excision of the tumor was performed with the patient in prone position. The tumor appeared cystic, with moderate bleeding and showed necrotic components. The tumor was resected down to the level of the fourth ventricle. Ventral to this level a separation from the cranial nerves and the brain stem was not possible, so that a significant amount of residual tumor remained. The postoperative course was uneventful. Apart from a slight strabismus there were no new postoperative neurological deficits. Due to a persisting hydrocephalus, a ventriculoperitoneal shunt was implanted 2 weeks later. The patient was discharged home 3 days after the second procedure. …

Spennato P, Nicosia G, Quaglietta L, Donofrio V, Mirone G, Di Martino G, Guadagno E, del Basso de Caro ML, Cascone D, Cinalli G. Posterior fossa tumors in infants and neonates. Childs Nerv Syst. 2015;31:175–7.CrossRef

Lee YY, Van Tassel P, Bruner JM, Moser RP, Share JC. Juvenile pilocytic astrocytomas: CT and MR characteristics. AJR Am J Roentgenol. 1989;152:1263–70.CrossRefPubMed

Nakano Y, Yamamoto J, Takahashi M, Soejima Y, Akiba D, Kitagawa T, Ueta K, Miyaoka R, Umemura T, Nishizawa S. Pilocytic astrocytoma presenting with atypical features on magnetic resonance imaging. J Neuroradiol. 2015;42:278–82.CrossRefPubMed

Gaudino S, Martucci M, Russo R, Visconti E, Gangemi E, D’Argento F, Verdolotti T, Lauriola L, Colosimo C. MR imaging of brain pilocytic astrocytoma: Beyond the stereotype of benign astrocytoma. Childs Nerv Syst. 2017;33:35–54.CrossRefPubMed

Rumboldt Z, Camacho DL, Lake D, Welsh CT, Castillo M. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol. 2006;27(6):1362–9.PubMed

Zitouni S, Koc G, Doganay S, Saracoglu S, Gumus KZ, Ciraci S, Coskun A, Unal E, Per H, Kurtsoy A, Kontas O. Apparent diffusion coefficient in differentiation of pediatric posterior fossa tumors. Jpn J Radiol. 2017;35:448–53.CrossRefPubMed

Domínguez-Pinilla N, Martínez de Aragón A, Diéguez Tapias S, Toldos O, Hinojosa Bernal J, Rigal Andrés M, González-Granado LI. Evaluating the apparent diffusion coefficient in MRI studies as a means of determining paediatric brain tumour stages. Evaluación de la utilidad del coeficiente de difusión aparente en resonancia magnética para la diferenciación del grado tumoral de los tumores cerebrales pediátricos. Neurologia. 2016;31:459–65.CrossRefPubMed

Alkonyi B, Nowak J, Gnekow A, Pietsch T, Warmuth-Metz M. Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas. Neuroradiology. 2015;57:625–38.CrossRefPubMed

Colafati GS, Voicu IP, Carducci C, Miele E, Carai A, Di Loreto S, Marrazzo A, Cacchione A, Cecinati V, Tornesello A, Mastronuzzi A. MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: State of the art. Ther Adv Neurol Disord. 2018;11:17–9.CrossRef

10.

Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P1, Solomon DA1, Aboian M1, Cha S1, Mueller S1. Case-based review: Pediatric medulloblastoma. Neurooncol Pract. 2017;4:138–50.CrossRefPubMedPubMedCentral

11.

Rodriguez Gutierrez D, Awwad A, Meijer L, Manita M, Jaspan T, Dineen RA, Grundy RG, Auer DP. Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors. AJNR Am J Neuroradiol. 2014;35:1009–15.CrossRefPubMed

12.

Erdem E, Zimmerman RA, Haselgrove JC, Bilaniuk LT, Hunter JV. Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors. Neuroradiology. 2001;43:927–33.CrossRefPubMed

13.

Rollins N, Mendelsohn D, Mulne A, Barton R, Diehl J, Reyes N, Sklar F. Recurrent medulloblastoma: Frequency of tumor enhancement on Gd-DTPA MR imaging. AJNR Am J Neuroradiol. 1990;11:583–7.PubMed

14.

Bühring U, Strayle-Batra M, Freudenstein D, Scheel-Walter HG, Küker W. MRI features of primary, secondary and metastatic medulloblastoma. Eur Radiol. 2002;12:1342–8.CrossRefPubMed

15.

Aboian MS, Kline CN, Li Y, Solomon DA, Felton E, Banerjee A, Braunstein SE, Mueller S, Dillon WP, Cha S. Early detection of recurrent medulloblastoma: The critical role of diffusion-weighted imaging. Neurooncol Pract. 2018;5:234–40.PubMed

16.

Koral K, Gargan L, Bowers DC, Gimi B, Timmons CF, Weprin B, Rollins NK. Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma. AJR Am J Roentgenol. 2008;190:809–14.CrossRefPubMed

17.

Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A. Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005;23:1491–9.CrossRefPubMed

18.

Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: Current therapy and future directions. Front Oncol. 2012;2:114.CrossRefPubMedPubMedCentral

19.

Zacharoulis S, Moreno L. Ependymoma: An update. J Child Neurol. 2009;24:1431–8.CrossRefPubMed

20.

Zacharoulis S, Ji L, Pollack IF, Duffner P, Geyer R, Grill J, Schild S, Jaing TH, Massimino M, Finlay J, Sposto R. Metastatic ependymoma: A multi-institutional retrospective analysis of prognostic factors. Pediatr Blood Cancer. 2008;50:231–5.CrossRefPubMed

21.

McKean-Cowdin R, Razavi P, Barrington-Trimis J, Baldwin RT, Asgharzadeh S, Cockburn M, Tihan T, Preston-Martin S. Trends in childhood brain tumor incidence, 1973–2009. J Neurooncol. 2013;115:153–60.CrossRefPubMedPubMedCentral

22.

Barkovich AJ. Pediatric neuroimaging. Philadelphia: Lippincott Williams & Wilkins; 2005.

23.

Swartz JD, Zimmerman RA, Bilaniuk LT. Computed tomography of intracranial ependymomas. Radiology. 1982;143:97–101.CrossRefPubMed

24.

Yuh EL, Barkovich AJ, Gupta N. Imaging of ependymomas: MRI and CT. Childs Nerv Syst. 2009;25:1203–13.CrossRefPubMedPubMedCentral

25.

Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J Neurooncol. 2011;104:423–38.CrossRefPubMed

26.

Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, Johnston D, Michaud J, La Spina M, Buccoliero AM, Adamek D, Camelo-Piragua S, Peter Collins V, Jones C, Kabbara N, Jurdi N, Varlet P, Perry A, Scharnhorst D, Fan X, Muraszko KM, Eberhart CG, Ng HK, Gururangan S, Van Meter T, Remke M, Lafay-Cousin L, Chan JA, Sirachainan N, Pomeroy SL, Clifford SC, Gajjar A, Shago M, Halliday W, Taylor MD, Grundy R, Lau CC, Phillips J, Bouffet E, Dirks PB, Hawkins CE, Huang A. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol. 2014;128:291–303.CrossRefPubMedPubMedCentral

27.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer; 2016.

28.

Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74–9.PubMed

29.

Purdy E, Johnston DL, Bartels U, Fryer C, Carret AS, Crooks B, Eisenstat DD, Lafay-Cousin L, Larouche V, Wilson B, Zelcer S, Silva M, Bouffet E, Keene D, Strother DR. Ependymoma in children under the age of 3 years: A report from the Canadian Pediatric Brain Tumour Consortium. J Neurooncol. 2014;117:359–64.CrossRefPubMed

30.

Duncan J, Lows E Jr. Intracranial ependymomas. In: Kaye A, Lows E Jr, editors. Brain tumors. Edinburgh: Churchill Livingstone; 1995. pp. 493–504.

31.

Taschner CA, Erny D, Shah MJ, Urbach H, Lutz K, Prinz M. Freiburg Neuropathology Case Conference: An infant with a supratentorial mass lesion. Clin Neuroradiol. 2015;25:211–7.CrossRefPubMed

32.

Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T, Frappaz D, Massimino M, Grill J, Boyett JM, Grundy RG. Histopathological grading of pediatric ependymoma: Reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed. 2011;10:7.CrossRefPubMedPubMedCentral

33.

Hubner JM, Kool M, Pfister SM, Pajtler KW. Epidemiology, molecular classification and WHO grading of ependymoma. J Neurosurg Sci. 2018;62:46–50.PubMed

34.

Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27:728–43.CrossRefPubMedPubMedCentral

35.

Capper D, Weissert S, Balss J, Habel A, Meyer J, Jäger D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol. 2010;20:245–54.CrossRefPubMed

Titel: Freiburg Neuropathology Case Conference
Posterior Fossa Mass in an Infant
Publikationsdatum: 07.02.2019
Erschienen in: Clinical Neuroradiology / Ausgabe 1/2019
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI: https://doi.org/10.1007/s00062-019-00759-3

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Freiburg Neuropathology Case Conference

Posterior Fossa Mass in an Infant

Excerpt

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Update Radiologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Mechanical Thrombectomy in Basilar Artery Occlusion

Iatrogenic Vessel Dissection in Endovascular Treatment of Acute Ischemic Stroke

Proton Density Fat Suppressed MRI in 3T Increases the Sensitivity of Multiple Sclerosis Lesion Detection in the Cervical Spinal Cord

Diffusion-Weighted MRI Stroke Volume Following Recanalization Treatment is Threshold-Dependent

Computed Tomography Perfusion is a Useful Adjunct to Computed Tomography Angiography in the Diagnosis of Brain Death

Information

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Update Radiologie